Judges Scientific plc (LON:JDG – Get Free Report) insider Tim Prestidge acquired 3 shares of the stock in a transaction dated Monday, January 5th. The stock was acquired at an average price of GBX 5,753 per share, for a total transaction of £172.59.
Judges Scientific Stock Down 0.3%
Shares of JDG opened at GBX 5,700 on Friday. The company has a market capitalization of £379.11 million, a PE ratio of 34.97, a price-to-earnings-growth ratio of 0.56 and a beta of 0.83. The company has a current ratio of 1.97, a quick ratio of 0.65 and a debt-to-equity ratio of 70.79. Judges Scientific plc has a 12-month low of GBX 4,400 and a 12-month high of GBX 9,120. The business’s 50 day moving average is GBX 5,467.10 and its 200 day moving average is GBX 6,284.70.
Analysts Set New Price Targets
Several analysts recently weighed in on JDG shares. Berenberg Bank restated a “buy” rating and set a GBX 7,900 price target on shares of Judges Scientific in a report on Wednesday, November 26th. Jefferies Financial Group reissued a “buy” rating and set a GBX 7,380 target price on shares of Judges Scientific in a research report on Tuesday, November 4th. Finally, Shore Capital reiterated a “house stock” rating on shares of Judges Scientific in a research note on Thursday, September 18th. Two analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of GBX 7,640.
Judges Scientific News Roundup
Here are the key news stories impacting Judges Scientific this week:
- Positive Sentiment: Multiple insiders (including David Cicurel, Bradley Ormsby, Tim Prestidge and Ian Wilcock) purchased small lots (3 shares each) at ~GBX 5,753 on Jan 5 — a signal of insider confidence but immaterial in size. MarketBeat Insider Trades
- Positive Sentiment: Brokers have reaffirmed constructive ratings (Jefferies and Berenberg reiterating buys with targets ~GBX 7,380–7,900; consensus target ~GBX 7,640), which supports upside vs. the current price. MarketBeat Analyst Notes
- Neutral Sentiment: Judges remains an acquisitive group focused on niche scientific-instrument businesses (23 subsidiaries) — a steady, long-term strategy but one that can make near-term performance dependent on acquisition timing and integration. Company Profile
- Negative Sentiment: Balance-sheet and liquidity metrics may worry investors: a high debt-to-equity (~70.8%) and a quick ratio below 1 (0.65) increase sensitivity to earnings volatility. Financial Metrics
- Negative Sentiment: Technical weakness: the share price sits below the 200‑day moving average (GBX 6,308) and near the 50‑day, which can prompt tactical selling; intraday volume above average suggests higher selling pressure today. Price & Volume Data
About Judges Scientific
Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 23 businesses acquired since 2005.
The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen’s Awards for innovation and export.
The Group’s companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.
Read More
- Five stocks we like better than Judges Scientific
- Wall Street Stockpicker Names #1 Stock of 2026
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Nvidia x 1,000,000
Receive News & Ratings for Judges Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Judges Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
